APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Proteomics Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Proteomics Services Market Outlook and Growth Opportunities 2026

12 August 2026212 pages

Choose your research edition.

Industry ResearchBlood Proteomics Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Proteomics Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Blood Proteomics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Proteomics Services Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Proteomics Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Blood Proteomics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Proteomics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Proteomics Services market include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Blood Proteomics Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Proteomics Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Proteomics Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Proteomics Services market.

Blood Proteomics Services Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Blood Proteomics Services Segment by Type

Blood Proteomics

Blood Modification Proteomics

Olink (Targeted) Proteomics

Blood Proteomics Services Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Blood Proteomics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Proteomics Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Proteomics Services key companies, revenue, market share, and recent developments.

3. To split the Blood Proteomics Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Proteomics Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Proteomics Services significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Proteomics Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Proteomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Proteomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Proteomics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Proteomics Services industry.

Chapter 3: Detailed analysis of Blood Proteomics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Proteomics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Proteomics Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Proteomics Services Industry Trends Table 2. Blood Proteomics Services Industry Drivers Table 3. Blood Proteomics Services Industry Opportunities and Challenges Table 4. Blood Proteomics Services Industry Restraints Table 5. Global Blood Proteomics Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Proteomics Services Revenue Share by Company (2021-2026) Table 7. Global Blood Proteomics Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Proteomics Services Key Company Manufacturing Base & Headquarters Table 9. Global Blood Proteomics Services Company, Product Type & Application Table 10. Global Blood Proteomics Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Proteomics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Blood Proteomics Table 15. Significant Companies of Blood Modification Proteomics Table 16. Significant Companies of Olink (Targeted) Proteomics Table 17. Global Blood Proteomics Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Blood Proteomics Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Blood Proteomics Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Blood Proteomics Services Sales Value Share by Type (2021-2026) Table 21. Global Blood Proteomics Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Disease Biomarker Research Table 23. Significant Companies of Drug Development Table 24. Significant Companies of Clinical Research Table 25. Significant Companies of Others Table 26. Global Blood Proteomics Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Blood Proteomics Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Blood Proteomics Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Blood Proteomics Services Sales Value Share by Application (2021-2026) Table 30. Global Blood Proteomics Services Sales Value Share by Application (2027-2032) Table 31. Global Blood Proteomics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Blood Proteomics Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Blood Proteomics Services Sales Value Share by Region (2021-2026) Table 34. Global Blood Proteomics Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Blood Proteomics Services Sales Value Share by Region (2027-2032) Table 36. Global Blood Proteomics Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Blood Proteomics Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Blood Proteomics Services Sales Value Market Share by Country (2021-2026) Table 39. Global Blood Proteomics Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Blood Proteomics Services Sales Value Market Share by Country (2027-2032) Table 41. BostonGene Company Information Table 42. BostonGene Business Overview Table 43. BostonGene Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. BostonGene Blood Proteomics Services Product Portfolio Table 45. BostonGene Recent Development Table 46. CellCarta Company Information Table 47. CellCarta Business Overview Table 48. CellCarta Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. CellCarta Blood Proteomics Services Product Portfolio Table 50. CellCarta Recent Development Table 51. GENEWIZ (Azenta Life Sciences) Company Information Table 52. GENEWIZ (Azenta Life Sciences) Business Overview Table 53. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio Table 55. GENEWIZ (Azenta Life Sciences) Recent Development Table 56. CDI Labs Company Information Table 57. CDI Labs Business Overview Table 58. CDI Labs Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. CDI Labs Blood Proteomics Services Product Portfolio Table 60. CDI Labs Recent Development Table 61. Biognosys Company Information Table 62. Biognosys Business Overview Table 63. Biognosys Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Biognosys Blood Proteomics Services Product Portfolio Table 65. Biognosys Recent Development Table 66. Discovery Life Sciences Company Information Table 67. Discovery Life Sciences Business Overview Table 68. Discovery Life Sciences Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Discovery Life Sciences Blood Proteomics Services Product Portfolio Table 70. Discovery Life Sciences Recent Development Table 71. Firalis Molecular Precision Company Information Table 72. Firalis Molecular Precision Business Overview Table 73. Firalis Molecular Precision Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Firalis Molecular Precision Blood Proteomics Services Product Portfolio Table 75. Firalis Molecular Precision Recent Development Table 76. Cell Signaling Technology (CST) Company Information Table 77. Cell Signaling Technology (CST) Business Overview Table 78. Cell Signaling Technology (CST) Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio Table 80. Cell Signaling Technology (CST) Recent Development Table 81. Sampled (Infinity Biologix) Company Information Table 82. Sampled (Infinity Biologix) Business Overview Table 83. Sampled (Infinity Biologix) Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio Table 85. Sampled (Infinity Biologix) Recent Development Table 86. APTBIO Company Information Table 87. APTBIO Business Overview Table 88. APTBIO Blood Proteomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. APTBIO Blood Proteomics Services Product Portfolio Table 90. APTBIO Recent Development Table 91. Sinotech Genomics Company Information Table 92. Sinotech Genomics Business Overview Table 93. Sinotech Genomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sinotech Genomics Blood Proteomics Services Product Portfolio Table 95. Sinotech Genomics Recent Development Table 96. Biodesix Company Information Table 97. Biodesix Business Overview Table 98. Biodesix Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Biodesix Blood Proteomics Services Product Portfolio Table 100. Biodesix Recent Development Table 101. Panome Bio Company Information Table 102. Panome Bio Business Overview Table 103. Panome Bio Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Panome Bio Blood Proteomics Services Product Portfolio Table 105. Panome Bio Recent Development Table 106. Novogene Company Information Table 107. Novogene Business Overview Table 108. Novogene Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Novogene Blood Proteomics Services Product Portfolio Table 110. Novogene Recent Development Table 111. PTM BIO Company Information Table 112. PTM BIO Business Overview Table 113. PTM BIO Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. PTM BIO Blood Proteomics Services Product Portfolio Table 115. PTM BIO Recent Development Table 116. BGI Genomics Company Information Table 117. BGI Genomics Business Overview Table 118. BGI Genomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. BGI Genomics Blood Proteomics Services Product Portfolio Table 120. BGI Genomics Recent Development Table 121. Evotec Company Information Table 122. Evotec Business Overview Table 123. Evotec Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Evotec Blood Proteomics Services Product Portfolio Table 125. Evotec Recent Development Table 126. Metware Biotechnology Company Information Table 127. Metware Biotechnology Business Overview Table 128. Metware Biotechnology Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Metware Biotechnology Blood Proteomics Services Product Portfolio Table 130. Metware Biotechnology Recent Development Table 131. MRM Proteomics Company Information Table 132. MRM Proteomics Business Overview Table 133. MRM Proteomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. MRM Proteomics Blood Proteomics Services Product Portfolio Table 135. MRM Proteomics Recent Development Table 136. Lc-Bio Technologies Company Information Table 137. Lc-Bio Technologies Business Overview Table 138. Lc-Bio Technologies Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Lc-Bio Technologies Blood Proteomics Services Product Portfolio Table 140. Lc-Bio Technologies Recent Development Table 141. Eurofins Scientific Company Information Table 142. Eurofins Scientific Business Overview Table 143. Eurofins Scientific Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Eurofins Scientific Blood Proteomics Services Product Portfolio Table 145. Eurofins Scientific Recent Development Table 146. MtoZ-Biolabs Company Information Table 147. MtoZ-Biolabs Business Overview Table 148. MtoZ-Biolabs Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. MtoZ-Biolabs Blood Proteomics Services Product Portfolio Table 150. MtoZ-Biolabs Recent Development Table 151. Creative Proteomics Company Information Table 152. Creative Proteomics Business Overview Table 153. Creative Proteomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Creative Proteomics Blood Proteomics Services Product Portfolio Table 155. Creative Proteomics Recent Development Table 156. Macrogen Company Information Table 157. Macrogen Business Overview Table 158. Macrogen Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Macrogen Blood Proteomics Services Product Portfolio Table 160. Macrogen Recent Development Table 161. TATAA Biocenter Company Information Table 162. TATAA Biocenter Business Overview Table 163. TATAA Biocenter Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. TATAA Biocenter Blood Proteomics Services Product Portfolio Table 165. TATAA Biocenter Recent Development Table 166. OmicScouts (Momentum Biotechnologies) Company Information Table 167. OmicScouts (Momentum Biotechnologies) Business Overview Table 168. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio Table 170. OmicScouts (Momentum Biotechnologies) Recent Development Table 171. Precision Biomarker Laboratories (PBL) Company Information Table 172. Precision Biomarker Laboratories (PBL) Business Overview Table 173. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio Table 175. Precision Biomarker Laboratories (PBL) Recent Development Table 176. Shanghai OE Biotech Company Information Table 177. Shanghai OE Biotech Business Overview Table 178. Shanghai OE Biotech Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Shanghai OE Biotech Blood Proteomics Services Product Portfolio Table 180. Shanghai OE Biotech Recent Development Table 181. RxCelerate Company Information Table 182. RxCelerate Business Overview Table 183. RxCelerate Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. RxCelerate Blood Proteomics Services Product Portfolio Table 185. RxCelerate Recent Development Table 186. Proteomics International Company Information Table 187. Proteomics International Business Overview Table 188. Proteomics International Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Proteomics International Blood Proteomics Services Product Portfolio Table 190. Proteomics International Recent Development Table 191. Proteome Sciences Company Information Table 192. Proteome Sciences Business Overview Table 193. Proteome Sciences Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Proteome Sciences Blood Proteomics Services Product Portfolio Table 195. Proteome Sciences Recent Development Table 196. Westlake Omics Company Information Table 197. Westlake Omics Business Overview Table 198. Westlake Omics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Westlake Omics Blood Proteomics Services Product Portfolio Table 200. Westlake Omics Recent Development Table 201. Crown Bioscience Company Information Table 202. Crown Bioscience Business Overview Table 203. Crown Bioscience Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. Crown Bioscience Blood Proteomics Services Product Portfolio Table 205. Crown Bioscience Recent Development Table 206. VProteomics Company Information Table 207. VProteomics Business Overview Table 208. VProteomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. VProteomics Blood Proteomics Services Product Portfolio Table 210. VProteomics Recent Development Table 211. Shanghai Majorbio Bio-Pharm Company Information Table 212. Shanghai Majorbio Bio-Pharm Business Overview Table 213. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio Table 215. Shanghai Majorbio Bio-Pharm Recent Development Table 216. Applied Biomics Company Information Table 217. Applied Biomics Business Overview Table 218. Applied Biomics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. Applied Biomics Blood Proteomics Services Product Portfolio Table 220. Applied Biomics Recent Development Table 221. Sapient Bioanalytics Company Information Table 222. Sapient Bioanalytics Business Overview Table 223. Sapient Bioanalytics Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 224. Sapient Bioanalytics Blood Proteomics Services Product Portfolio Table 225. Sapient Bioanalytics Recent Development Table 226. Allumiqs Company Information Table 227. Allumiqs Business Overview Table 228. Allumiqs Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 229. Allumiqs Blood Proteomics Services Product Portfolio Table 230. Allumiqs Recent Development Table 231. MS Bioworks Company Information Table 232. MS Bioworks Business Overview Table 233. MS Bioworks Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 234. MS Bioworks Blood Proteomics Services Product Portfolio Table 235. MS Bioworks Recent Development Table 236. Shanghai Bioprofile Company Information Table 237. Shanghai Bioprofile Business Overview Table 238. Shanghai Bioprofile Blood Proteomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 239. Shanghai Bioprofile Blood Proteomics Services Product Portfolio Table 240. Shanghai Bioprofile Recent Development Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Blood Proteomics Services Product Image Figure 2. Global Blood Proteomics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Proteomics Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Proteomics Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Blood Proteomics Image Figure 8. Blood Modification Proteomics Image Figure 9. Olink (Targeted) Proteomics Image Figure 10. Global Blood Proteomics Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Blood Proteomics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Blood Proteomics Services Sales Value Share by Type (2021-2032) Figure 13. Disease Biomarker Research Image Figure 14. Drug Development Image Figure 15. Clinical Research Image Figure 16. Others Image Figure 17. Global Blood Proteomics Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Blood Proteomics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Blood Proteomics Services Sales Value Share by Application (2021-2032) Figure 20. Global Blood Proteomics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Blood Proteomics Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Blood Proteomics Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Blood Proteomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Blood Proteomics Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Blood Proteomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Blood Proteomics Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Blood Proteomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Blood Proteomics Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Blood Proteomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Blood Proteomics Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Blood Proteomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Blood Proteomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Proteomics
  • Blood Modification Proteomics
  • Olink (Targeted) Proteomics
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Proteomics Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Proteomics Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Proteomics Services Market Dynamics
  1. 2.1 Blood Proteomics Services Industry Trends
  2. 2.2 Blood Proteomics Services Industry Drivers
  3. 2.3 Blood Proteomics Services Industry Opportunities and Challenges
  4. 2.4 Blood Proteomics Services Industry Restraints
3 Blood Proteomics Services Market by Company
  1. 3.1 Global Blood Proteomics Services Company Revenue Ranking in 2025
  2. 3.2 Global Blood Proteomics Services Revenue by Company (2021-2026)
  3. 3.3 Global Blood Proteomics Services Company Ranking (2024-2026)
  4. 3.4 Global Blood Proteomics Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Proteomics Services Company Product Type and Application
  6. 3.6 Global Blood Proteomics Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Proteomics Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Proteomics Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Proteomics Services Market by Type
  1. 4.1 Blood Proteomics Services Type Introduction
  2. 4.1.1 Blood Proteomics
  3. 4.1.2 Blood Modification Proteomics
  4. 4.1.3 Olink (Targeted) Proteomics
  5. 4.2 Global Blood Proteomics Services Sales Value by Type
  6. 4.2.1 Global Blood Proteomics Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Blood Proteomics Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Blood Proteomics Services Sales Value Share by Type (2021-2032)
5 Blood Proteomics Services Market by Application
  1. 5.1 Blood Proteomics Services Application Introduction
  2. 5.1.1 Disease Biomarker Research
  3. 5.1.2 Drug Development
  4. 5.1.3 Clinical Research
  5. 5.1.4 Others
  6. 5.2 Global Blood Proteomics Services Sales Value by Application
  7. 5.2.1 Global Blood Proteomics Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Blood Proteomics Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Blood Proteomics Services Sales Value Share by Application (2021-2032)
6 Blood Proteomics Services Regional Value Analysis
  1. 6.1 Global Blood Proteomics Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Proteomics Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Proteomics Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Proteomics Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Proteomics Services Sales Value (2021-2032)
  7. 6.3.2 North America Blood Proteomics Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Proteomics Services Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Proteomics Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Proteomics Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Proteomics Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Proteomics Services Sales Value (2021-2032)
  16. 6.6.2 South America Blood Proteomics Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Proteomics Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Proteomics Services Sales Value Share by Country, 2025 VS 2032
7 Blood Proteomics Services Country-level Value Analysis
  1. 7.1 Global Blood Proteomics Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Proteomics Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Proteomics Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Proteomics Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Proteomics Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Proteomics Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Proteomics Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BostonGene
  2. 8.1.1 BostonGene Company Information
  3. 8.1.2 BostonGene Business Overview
  4. 8.1.3 BostonGene Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BostonGene Blood Proteomics Services Product Portfolio
  6. 8.1.5 BostonGene Recent Developments
  7. 8.2 CellCarta
  8. 8.2.1 CellCarta Company Information
  9. 8.2.2 CellCarta Business Overview
  10. 8.2.3 CellCarta Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CellCarta Blood Proteomics Services Product Portfolio
  12. 8.2.5 CellCarta Recent Developments
  13. 8.3 GENEWIZ (Azenta Life Sciences)
  14. 8.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 8.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 8.3.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio
  18. 8.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 8.4 CDI Labs
  20. 8.4.1 CDI Labs Company Information
  21. 8.4.2 CDI Labs Business Overview
  22. 8.4.3 CDI Labs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CDI Labs Blood Proteomics Services Product Portfolio
  24. 8.4.5 CDI Labs Recent Developments
  25. 8.5 Biognosys
  26. 8.5.1 Biognosys Company Information
  27. 8.5.2 Biognosys Business Overview
  28. 8.5.3 Biognosys Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biognosys Blood Proteomics Services Product Portfolio
  30. 8.5.5 Biognosys Recent Developments
  31. 8.6 Discovery Life Sciences
  32. 8.6.1 Discovery Life Sciences Company Information
  33. 8.6.2 Discovery Life Sciences Business Overview
  34. 8.6.3 Discovery Life Sciences Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Discovery Life Sciences Blood Proteomics Services Product Portfolio
  36. 8.6.5 Discovery Life Sciences Recent Developments
  37. 8.7 Firalis Molecular Precision
  38. 8.7.1 Firalis Molecular Precision Company Information
  39. 8.7.2 Firalis Molecular Precision Business Overview
  40. 8.7.3 Firalis Molecular Precision Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Firalis Molecular Precision Blood Proteomics Services Product Portfolio
  42. 8.7.5 Firalis Molecular Precision Recent Developments
  43. 8.8 Cell Signaling Technology (CST)
  44. 8.8.1 Cell Signaling Technology (CST) Company Information
  45. 8.8.2 Cell Signaling Technology (CST) Business Overview
  46. 8.8.3 Cell Signaling Technology (CST) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio
  48. 8.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 8.9 Sampled (Infinity Biologix)
  50. 8.9.1 Sampled (Infinity Biologix) Company Information
  51. 8.9.2 Sampled (Infinity Biologix) Business Overview
  52. 8.9.3 Sampled (Infinity Biologix) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio
  54. 8.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 8.10 APTBIO
  56. 8.10.1 APTBIO Company Information
  57. 8.10.2 APTBIO Business Overview
  58. 8.10.3 APTBIO Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 APTBIO Blood Proteomics Services Product Portfolio
  60. 8.10.5 APTBIO Recent Developments
  61. 8.11 Sinotech Genomics
  62. 8.11.1 Sinotech Genomics Company Information
  63. 8.11.2 Sinotech Genomics Business Overview
  64. 8.11.3 Sinotech Genomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sinotech Genomics Blood Proteomics Services Product Portfolio
  66. 8.11.5 Sinotech Genomics Recent Developments
  67. 8.12 Biodesix
  68. 8.12.1 Biodesix Company Information
  69. 8.12.2 Biodesix Business Overview
  70. 8.12.3 Biodesix Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biodesix Blood Proteomics Services Product Portfolio
  72. 8.12.5 Biodesix Recent Developments
  73. 8.13 Panome Bio
  74. 8.13.1 Panome Bio Company Information
  75. 8.13.2 Panome Bio Business Overview
  76. 8.13.3 Panome Bio Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Panome Bio Blood Proteomics Services Product Portfolio
  78. 8.13.5 Panome Bio Recent Developments
  79. 8.14 Novogene
  80. 8.14.1 Novogene Company Information
  81. 8.14.2 Novogene Business Overview
  82. 8.14.3 Novogene Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novogene Blood Proteomics Services Product Portfolio
  84. 8.14.5 Novogene Recent Developments
  85. 8.15 PTM BIO
  86. 8.15.1 PTM BIO Company Information
  87. 8.15.2 PTM BIO Business Overview
  88. 8.15.3 PTM BIO Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PTM BIO Blood Proteomics Services Product Portfolio
  90. 8.15.5 PTM BIO Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Blood Proteomics Services Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 Evotec
  98. 8.17.1 Evotec Company Information
  99. 8.17.2 Evotec Business Overview
  100. 8.17.3 Evotec Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Evotec Blood Proteomics Services Product Portfolio
  102. 8.17.5 Evotec Recent Developments
  103. 8.18 Metware Biotechnology
  104. 8.18.1 Metware Biotechnology Company Information
  105. 8.18.2 Metware Biotechnology Business Overview
  106. 8.18.3 Metware Biotechnology Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Metware Biotechnology Blood Proteomics Services Product Portfolio
  108. 8.18.5 Metware Biotechnology Recent Developments
  109. 8.19 MRM Proteomics
  110. 8.19.1 MRM Proteomics Company Information
  111. 8.19.2 MRM Proteomics Business Overview
  112. 8.19.3 MRM Proteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MRM Proteomics Blood Proteomics Services Product Portfolio
  114. 8.19.5 MRM Proteomics Recent Developments
  115. 8.20 Lc-Bio Technologies
  116. 8.20.1 Lc-Bio Technologies Company Information
  117. 8.20.2 Lc-Bio Technologies Business Overview
  118. 8.20.3 Lc-Bio Technologies Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lc-Bio Technologies Blood Proteomics Services Product Portfolio
  120. 8.20.5 Lc-Bio Technologies Recent Developments
  121. 8.21 Eurofins Scientific
  122. 8.21.1 Eurofins Scientific Company Information
  123. 8.21.2 Eurofins Scientific Business Overview
  124. 8.21.3 Eurofins Scientific Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Eurofins Scientific Blood Proteomics Services Product Portfolio
  126. 8.21.5 Eurofins Scientific Recent Developments
  127. 8.22 MtoZ-Biolabs
  128. 8.22.1 MtoZ-Biolabs Company Information
  129. 8.22.2 MtoZ-Biolabs Business Overview
  130. 8.22.3 MtoZ-Biolabs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MtoZ-Biolabs Blood Proteomics Services Product Portfolio
  132. 8.22.5 MtoZ-Biolabs Recent Developments
  133. 8.23 Creative Proteomics
  134. 8.23.1 Creative Proteomics Company Information
  135. 8.23.2 Creative Proteomics Business Overview
  136. 8.23.3 Creative Proteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Creative Proteomics Blood Proteomics Services Product Portfolio
  138. 8.23.5 Creative Proteomics Recent Developments
  139. 8.24 Macrogen
  140. 8.24.1 Macrogen Company Information
  141. 8.24.2 Macrogen Business Overview
  142. 8.24.3 Macrogen Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Macrogen Blood Proteomics Services Product Portfolio
  144. 8.24.5 Macrogen Recent Developments
  145. 8.25 TATAA Biocenter
  146. 8.25.1 TATAA Biocenter Company Information
  147. 8.25.2 TATAA Biocenter Business Overview
  148. 8.25.3 TATAA Biocenter Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 TATAA Biocenter Blood Proteomics Services Product Portfolio
  150. 8.25.5 TATAA Biocenter Recent Developments
  151. 8.26 OmicScouts (Momentum Biotechnologies)
  152. 8.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 8.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 8.26.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio
  156. 8.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 8.27 Precision Biomarker Laboratories (PBL)
  158. 8.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 8.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 8.27.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio
  162. 8.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 8.28 Shanghai OE Biotech
  164. 8.28.1 Shanghai OE Biotech Company Information
  165. 8.28.2 Shanghai OE Biotech Business Overview
  166. 8.28.3 Shanghai OE Biotech Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Shanghai OE Biotech Blood Proteomics Services Product Portfolio
  168. 8.28.5 Shanghai OE Biotech Recent Developments
  169. 8.29 RxCelerate
  170. 8.29.1 RxCelerate Company Information
  171. 8.29.2 RxCelerate Business Overview
  172. 8.29.3 RxCelerate Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  173. 8.29.4 RxCelerate Blood Proteomics Services Product Portfolio
  174. 8.29.5 RxCelerate Recent Developments
  175. 8.30 Proteomics International
  176. 8.30.1 Proteomics International Company Information
  177. 8.30.2 Proteomics International Business Overview
  178. 8.30.3 Proteomics International Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Proteomics International Blood Proteomics Services Product Portfolio
  180. 8.30.5 Proteomics International Recent Developments
  181. 8.31 Proteome Sciences
  182. 8.31.1 Proteome Sciences Company Information
  183. 8.31.2 Proteome Sciences Business Overview
  184. 8.31.3 Proteome Sciences Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Proteome Sciences Blood Proteomics Services Product Portfolio
  186. 8.31.5 Proteome Sciences Recent Developments
  187. 8.32 Westlake Omics
  188. 8.32.1 Westlake Omics Company Information
  189. 8.32.2 Westlake Omics Business Overview
  190. 8.32.3 Westlake Omics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Westlake Omics Blood Proteomics Services Product Portfolio
  192. 8.32.5 Westlake Omics Recent Developments
  193. 8.33 Crown Bioscience
  194. 8.33.1 Crown Bioscience Company Information
  195. 8.33.2 Crown Bioscience Business Overview
  196. 8.33.3 Crown Bioscience Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Crown Bioscience Blood Proteomics Services Product Portfolio
  198. 8.33.5 Crown Bioscience Recent Developments
  199. 8.34 VProteomics
  200. 8.34.1 VProteomics Company Information
  201. 8.34.2 VProteomics Business Overview
  202. 8.34.3 VProteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  203. 8.34.4 VProteomics Blood Proteomics Services Product Portfolio
  204. 8.34.5 VProteomics Recent Developments
  205. 8.35 Shanghai Majorbio Bio-Pharm
  206. 8.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 8.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 8.35.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio
  210. 8.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 8.36 Applied Biomics
  212. 8.36.1 Applied Biomics Company Information
  213. 8.36.2 Applied Biomics Business Overview
  214. 8.36.3 Applied Biomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Applied Biomics Blood Proteomics Services Product Portfolio
  216. 8.36.5 Applied Biomics Recent Developments
  217. 8.37 Sapient Bioanalytics
  218. 8.37.1 Sapient Bioanalytics Company Information
  219. 8.37.2 Sapient Bioanalytics Business Overview
  220. 8.37.3 Sapient Bioanalytics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Sapient Bioanalytics Blood Proteomics Services Product Portfolio
  222. 8.37.5 Sapient Bioanalytics Recent Developments
  223. 8.38 Allumiqs
  224. 8.38.1 Allumiqs Company Information
  225. 8.38.2 Allumiqs Business Overview
  226. 8.38.3 Allumiqs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Allumiqs Blood Proteomics Services Product Portfolio
  228. 8.38.5 Allumiqs Recent Developments
  229. 8.39 MS Bioworks
  230. 8.39.1 MS Bioworks Company Information
  231. 8.39.2 MS Bioworks Business Overview
  232. 8.39.3 MS Bioworks Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  233. 8.39.4 MS Bioworks Blood Proteomics Services Product Portfolio
  234. 8.39.5 MS Bioworks Recent Developments
  235. 8.40 Shanghai Bioprofile
  236. 8.40.1 Shanghai Bioprofile Company Information
  237. 8.40.2 Shanghai Bioprofile Business Overview
  238. 8.40.3 Shanghai Bioprofile Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Shanghai Bioprofile Blood Proteomics Services Product Portfolio
  240. 8.40.5 Shanghai Bioprofile Recent Developments
  241. 8.41 Cosmos Wisdom
  242. 8.42 Olink (Thermo Fisher Scientific)
  243. 8.43 SomaLogic (Illumina)
  244. 8.44 Labcorp
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst